Average Co-Inventor Count = 2.19
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim (canada) Ltd. (12 from 62 patents)
2. Vida Therapeutics Inc. (10 from 10 patents)
3. Migenix, Inc. (2 from 20 patents)
4. Carrus Capital Corporation (2 from 6 patents)
5. Biowest Therapeutics Inc. (1 from 1 patent)
27 patents:
1. 10537652 - Cyclic urea compounds as granzyme B inhibitors
2. 10329324 - Indoline compounds as granzyme B inhibitors
3. 10246487 - Azaindoline compounds as granzyme B inhibitors
4. 9969772 - Covalent granzyme B inhibitors
5. 9969770 - Proline compounds as Granzyme B inhibitors
6. 9872885 - Antimicrobial and anti-inflammatory peptides
7. 9849112 - Pyrrole compounds as Granzyme B inhibitors
8. 9605021 - Indoline compounds as granzyme B inhibitors
9. 9458192 - Covalent granzyme B inhibitors
10. 9458193 - Proline compounds as Granzyme B inhibitors
11. 9458138 - Pyrrole compounds as granzyme B inhibitors
12. 8933029 - Antimicrobial and anti-inflammatory peptides
13. RE42164 - Hepatitis C inhibitor tri-peptides
14. 7868135 - Compositions of lipopeptide antibiotic derivatives and methods of use thereof
15. RE41894 - Hepatitis C inhibitor tri-peptides